Loading…
Loading…
IPDQF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for IPDQF and 80,000+ other tickers.
See exactly how IPDQF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IPDQF and 80,000+ other tickers.
ImpediMed Limited is a medical technology firm that specializes in software solutions. The company is involved in the creation, production, and global distribution of sophisticated bioimpedance spectroscopy (BIS) equipment and its accompanying software applications, serving markets in Australia, North America, and beyond. Its principal offerings include: SOZO: A non-intrusive BIS device engineered for the evaluation of lymphedema and for tracking fluid levels in individuals afflicted with heart failure. SFB7: A single-channel, tetrapolar BIS instrument utilized to assess the body composition…
ImpediMed Limited (IPDQF) Q4 2026 Earnings Call Transcript
ImpediMed Limited (IPDQF) Shareholder/Analyst Call Transcript
ImpediMed Limited (IPDQF) Shareholder/Analyst Call Prepared Remarks Transcript
ImpediMed Limited (IPDQF) Q2 2026 Earnings Call Transcript